{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T02:08:09Z","timestamp":1783908489515,"version":"3.55.0"},"reference-count":19,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cerebellar ataxia, mental retardation, and disequilibrium syndrome (CAMRQ) is a genetically and clinically heterogeneous disorder with four described subtypes. Autosomal recessive syndrome of cerebellar ataxia, mental retardation, and disequilibrium type 4 (CAMRQ4) is caused by mutations in the\n                    <jats:italic>ATP8A2<\/jats:italic>\n                    gene. We report an 8-year-old boy with choreoathetosis, hypotonia, without the ability to keep his head up and profound mental retardation. There was quadrupedal locomotion, as well. MRI of the brain revealed a hypotrophy of the corpus callosum, diffuse white matter reduction, widespread delayed myelination and ventriculomegaly. Trio whole-exome sequencing revealed compound heterozygosity in the\n                    <jats:italic>ATP8A2<\/jats:italic>\n                    gene consisting of a known variant c.1756C&gt;T (p.Arg586*) inherited from the mother and a novel variant c.691_701delCTGATGAAGTT (p.Leu231fs) inherited from the father. CAMRQ type 4 has been found in about 50 patients. To the best of our knowledge, this is the first reported patient with CAMRQ4 with these gene variants. The clinical presentation is severe.\n                  <\/jats:p>","DOI":"10.2478\/prilozi-2023-0051","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T14:48:40Z","timestamp":1702910920000},"page":"85-90","source":"Crossref","is-referenced-by-count":1,"title":["Compound Heterozygosity in Cerebellar Ataxia, Mental Retardation, and Disequilibrium Syndrome Type 4"],"prefix":"10.2478","volume":"44","author":[{"given":"Bojan","family":"Teov","sequence":"first","affiliation":[{"name":"University Children\u2019s Hospital , Medical Faculty Skopje , North Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Janchevska","sequence":"additional","affiliation":[{"name":"University Children\u2019s Hospital , Medical Faculty Skopje , North Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardiana","family":"Beqiri-Jasari","sequence":"additional","affiliation":[{"name":"University Children\u2019s Hospital , Medical Faculty Skopje , North Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velibor","family":"Tasic","sequence":"additional","affiliation":[{"name":"University Children\u2019s Hospital , Medical Faculty Skopje , North Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Kungulovski","sequence":"additional","affiliation":[{"name":"Bio Engineering LLC , Skopje , North Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Gucev","sequence":"additional","affiliation":[{"name":"University Children\u2019s Hospital , Medical Faculty Skopje , North Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"2026071211414304774_j_prilozi-2023-0051_ref_001","doi-asserted-by":"crossref","unstructured":"Gulsuner S, Tekinay AB, Doerschner K, et al. Homozygosity mapping and targeted genomic sequencing reveal the gene responsible for cerebellar hypoplasia and quadrupedal locomotion in a consanguineous kindred. Genome Res 2011 Dec 1;21(12):1995-2003.","DOI":"10.1101\/gr.126110.111"},{"key":"2026071211414304774_j_prilozi-2023-0051_ref_002","doi-asserted-by":"crossref","unstructured":"Emre Onat O, Gulsuner S, Bilguvar K, et al. Mis-sense mutation in the ATPase, aminophospholipid transporter protein ATP8A2 is associated with cerebellar atrophy and quadrupedal locomotion. Eur J Hum Genet 2013 Mar;21(3):281-5.","DOI":"10.1038\/ejhg.2012.170"},{"key":"2026071211414304774_j_prilozi-2023-0051_ref_003","doi-asserted-by":"crossref","unstructured":"Moheb LA, Tzschach A, Garshasbi M, et al. Identification of a nonsense mutation in the very low-density lipoprotein receptor gene (VLDLR) in an Iranian family with dysequilibrium syndrome. Eur J Hum Genet 2008 Feb;16(2):270-3.","DOI":"10.1038\/sj.ejhg.5201967"},{"key":"2026071211414304774_j_prilozi-2023-0051_ref_004","doi-asserted-by":"crossref","unstructured":"Boycott KM, Bonnemann C, Herz J, et al. Mutations in VLDLR as a Cause for Autosomal Recessive Cerebellar Ataxia With Mental Retardation (Dysequilibrium Syndrome). J Child Neurol 2009 Oct;24(10):1310-5.","DOI":"10.1177\/0883073809332696"},{"key":"2026071211414304774_j_prilozi-2023-0051_ref_005","doi-asserted-by":"crossref","unstructured":"T\u00fcrkmen S, Guo G, Garshasbi M, et al. CA8 mutations cause a novel syndrome characterized by ataxia and mild mental retardation with predisposition to quadrupedal gait. PLoS Genet 2009 May 22;5(5):e1000487.","DOI":"10.1371\/journal.pgen.1000487"},{"key":"2026071211414304774_j_prilozi-2023-0051_ref_006","doi-asserted-by":"crossref","unstructured":"Gantzel RH, Mogensen LS, Mikkelsen SA, et al. Disease mutations reveal residues critical to the interaction of P4-ATPases with lipid substrates. Sci Rep 2017 Sep 5;7(1):1-1.","DOI":"10.1038\/s41598-017-10741-z"},{"key":"2026071211414304774_j_prilozi-2023-0051_ref_007","doi-asserted-by":"crossref","unstructured":"Chang X, Wang K. wANNOVAR: annotating genetic variants for personal genomes via the web. J Med Genet 2012 Jul 1;49(7):433-6.","DOI":"10.1136\/jmedgenet-2012-100918"},{"key":"2026071211414304774_j_prilozi-2023-0051_ref_008","doi-asserted-by":"crossref","unstructured":"Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015 May;17(5):405-23.","DOI":"10.1038\/gim.2015.30"},{"key":"2026071211414304774_j_prilozi-2023-0051_ref_009","doi-asserted-by":"crossref","unstructured":"Cacciagli P, Haddad MR, Mignon-Ravix C, et al. Disruption of the ATP8A2 gene in a patient with a t(10;13) de novo balanced translocation and a severe neurological phenotype. Eur J Hum Genet 2010 Dec;18(12):1360-3.","DOI":"10.1038\/ejhg.2010.126"},{"key":"2026071211414304774_j_prilozi-2023-0051_ref_010","doi-asserted-by":"crossref","unstructured":"Tan U. Evidence for \u201cUnertan Syndrome\u201d and the evolution of the human mind. Int J Neurosci 2006 Jan 1;116(7):763-74.","DOI":"10.1080\/00207450600588733"},{"key":"2026071211414304774_j_prilozi-2023-0051_ref_011","doi-asserted-by":"crossref","unstructured":"Mart\u00edn-Hern\u00e1ndez E, Rodr\u00edguez-Garc\u00eda ME, Camacho A, et al. New ATP8A2 gene mutations associated with a novel syndrome: encephalopathy, intellectual disability, severe hypotonia, chorea and optic atrophy. Neurogenetics 2016 Oct;17(4):259-63.","DOI":"10.1007\/s10048-016-0496-y"},{"key":"2026071211414304774_j_prilozi-2023-0051_ref_012","doi-asserted-by":"crossref","unstructured":"Quintas S, Moldovan O, dos Santos TP, Levy A. New syndrome associated with ATP8A2 gene mutations: Encephalopathy, intellectual disability, severe hypotonia, chorea and optic atrophy Whole-exome sequencing role in the diagnosis of new diseases. Eur J Paediatr Neurol. 2017 Jun 1;21:e65.","DOI":"10.1016\/j.ejpn.2017.04.935"},{"key":"2026071211414304774_j_prilozi-2023-0051_ref_013","doi-asserted-by":"crossref","unstructured":"Alsahli S, Alrifai MT, Al Tala S, Mutairi FA, Alfadhel M. Further Delineation of the Clinical Phenotype of Cerebellar Ataxia, Mental Retardation, and Disequilibrium Syndrome Type 4. J Cent Nerv Syst Dis 2018 Feb 26;10:1179573518759682.","DOI":"10.1177\/1179573518759682"},{"key":"2026071211414304774_j_prilozi-2023-0051_ref_014","doi-asserted-by":"crossref","unstructured":"McMillan HJ, Telegrafi A, Singleton A, et al. Recessive mutations in ATP8A2 cause severe hypotonia, cognitive impairment, hyperkinetic movement disorders and progressive optic atrophy. Orphanet J Fare Dis 2018 Dec;13(1):1-0.","DOI":"10.1186\/s13023-018-0825-3"},{"key":"2026071211414304774_j_prilozi-2023-0051_ref_015","doi-asserted-by":"crossref","unstructured":"Guissart C, Harrison AN, Benkirane M, et al. ATP8A2-related disorders as recessive cerebellar ataxia. J Neurol 2020 Jan;267(1):203-13.","DOI":"10.1007\/s00415-019-09579-4"},{"key":"2026071211414304774_j_prilozi-2023-0051_ref_016","doi-asserted-by":"crossref","unstructured":"Mohamadian M, Ghandil P, Naseri M, Bahrami A, Momen AA. A novel homozygous variant in an Iranian pedigree with cerebellar ataxia, mental retardation, and dysequilibrium syndrome type 4. J Clin Lab 2020 Nov;34(11):e23484.","DOI":"10.1002\/jcla.23484"},{"key":"2026071211414304774_j_prilozi-2023-0051_ref_017","doi-asserted-by":"crossref","unstructured":"Heidari E, Harrison AN, Jafarinia E, et al. Novel variants in critical domains of ATP8A2 and expansion of clinical spectrum. Hum Mutat 2021 May;42(5):491-7.","DOI":"10.1002\/humu.24180"},{"key":"2026071211414304774_j_prilozi-2023-0051_ref_018","doi-asserted-by":"crossref","unstructured":"Dam\u00e1sio J, Santos D, Morais S, et al. Congenital ataxia due to novel variant in ATP8A2. Clin Genet 2021 Jul;100(1):79-83.","DOI":"10.1111\/cge.13954"},{"key":"2026071211414304774_j_prilozi-2023-0051_ref_019","doi-asserted-by":"crossref","unstructured":"Narishige Y, Yaoita H, Shibuya M, et al. Two Siblings with Cerebellar Ataxia, Mental Retardation, and Disequilibrium Syndrome 4 and a Novel Variant of ATP8A2. Tohoku J Exp Med 2022.","DOI":"10.1620\/tjem.2022.J010"}],"container-title":["PRILOZI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/prilozi-2023-0051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:38:08Z","timestamp":1783906688000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/prilozi-2023-0051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,12,18]]},"published-print":{"date-parts":[[2023,12,1]]}},"alternative-id":["10.2478\/prilozi-2023-0051"],"URL":"https:\/\/doi.org\/10.2478\/prilozi-2023-0051","relation":{},"ISSN":["1857-8985"],"issn-type":[{"value":"1857-8985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]}}}